Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 17, 2014 08:31 ET | Source: iBio, Inc.

iBio Expands Commercial Collaboration With Bio-Manguinhos and Fraunhofer

NEWARK, DE--(Marketwired - Jun 17, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, amended its...
June 10, 2014 08:31 ET | Source: iBio, Inc.

iBio Expands IP Protection of Biotherapeutic Product for Treatment of Fibrosis

NEWARK, DE--(Marketwired - Jun 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue by...
June 05, 2014 08:31 ET | Source: iBio, Inc.

iBio European Patent on iBioModulator Technology Emerges From Opposition Period

NEWARK, DE--(Marketwired - Jun 5, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, has surpassed the opposition...
April 24, 2014 08:31 ET | Source: iBio, Inc.

iBio Receives Patent Allowance in China for Fusion Protein Compositions and Technology

NEWARK, DE--(Marketwired - Apr 24, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance...
March 27, 2014 08:31 ET | Source: iBio, Inc.

iBio Receives Patent Allowances for Pandemic Influenza Therapeutics

NEWARK, DE--(Marketwired - Mar 27, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance of two U.S....
March 04, 2014 08:31 ET | Source: iBio, Inc.

iBio to Present at the 26th Annual ROTH Conference on March 10, 2014

NEWARK, DE--(Marketwired - Mar 4, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, has been invited to present at the...
February 10, 2014 08:31 ET | Source: iBio, Inc.

Phase 1 Clinical Trial Begins for Malaria Vaccine Candidate Based on iBio's Proprietary Technology

NEWARK, DE--(Marketwired - Feb 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the initiation of a...
January 30, 2014 08:31 ET | Source: iBio, Inc.

iBio Adds Biotherapeutic Product for Treatment of Fibrosis to Its Proprietary Product Pipeline

NEWARK, DE--(Marketwired - Jan 30, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biopharmaceutical products, has added a...
January 21, 2014 08:31 ET | Source: iBio, Inc.

iBio Receives Allowance of Patent for HPV-Related Cancer Vaccine in China

NEWARK, DE--(Marketwired - Jan 21, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has received a notice...
January 15, 2014 08:31 ET | Source: iBio, Inc.

iBio and Caliber Designate New Fusion Protein as Target Product Under License and Collaboration Agreement

NEWARK, DE--(Marketwired - Jan 15, 2014) - iBio, Inc. (NYSE MKT: IBIO) announced today that the company and Caliber Biotherapeutics have designated a proprietary fusion protein for cancer...